Product Information
- (6aR,10aR)-3-(1,1-Dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol(6aR-trans)-3-(1,1-d imethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol(-)-HU-210
- (6AR,10aR)-3-(1,1-Dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo[b,d]pyran-9-methanol
- (6aR)-trans-3-(1,1-Dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-(6H)-dibenzo[b.d]pyran-9-methanol
- (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol
- (6aS,10aS)-3-(1,1-dimethylheptyl)-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,10a-tetrahydrobenzo[c]isochromen-1-ol
- 6H-Dibenzo[b,d]pyran-9-methanol, 3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-, (6aR,10aR)-
- 6H-Dibenzo[b,d]pyran-9-methanol, 3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-, (6aR-trans)-
- HU-210 DEA Schedule I
HU-210 is a synthetic cannabinoid receptor agonist with a strong affinity for the CB1 and CB2 receptor (Ki = 0.061 and 0.52 nM, respectively)1. In vitro, it has been shown to promote proliferation of embryonic neural stem cells in the hippocampus through the activation of Gi/o proteins and ERK signaling2. In vivo, it has been associated with counteracting amyloid beta-dependent inflammation in Alzheimer’s disease as well as preventing neuronal loss and cognitive decay. In vivo effects are thought to be mediated by CB1 and CB2 receptors mediated activation of microglia-secreted TNFα and other inflammatory markers3.
Chemical properties
Technical inquiry about: 3D-FH23866 HU 210
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
